Shockwave Medical Profit Margin

Shockwave Medical posts a profit margin of 20.75% as of March 2024. That compares with 43.18% in the prior-year period — down 51.9% year over year. That is above the Healthcare sector average of 15.29%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Shockwave Medical's profit margin was 43.18%. The latest reading is 20.75% — a 51.9% year-over-year decrease (period ending March 2024). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 15.29% is typical. Shockwave Medical's 20.75% is higher that level. That is roughly 35.7% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Shockwave Medical's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 20.75% as of March 2024; use YoY and peer views to separate noise from signal.

Context for SWAV's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 15.29%), and (3) consistency with growth and profitability. This page covers the first two; Shockwave Medical's other metric pages and overview cover the third.